Formosa Laboratories, Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Formosa Laboratories, Inc with three other
companies in this sector in Taiwan:
Sinphar Pharmaceutical C O., Ltd.
sales of 2.19 billion Taiwanese Dollars [US$68.49 million]
of which 66%
Tci Co Ltd
(2.06 billion Taiwanese Dollars [US$64.64 million]
of which 55%
was Asia), and
Tty Biopharm Company Limited
(3.20 billion Taiwanese Dollars [US$100.04 million]
of which 65%
was Anti-Cancer Drug).
Formosa Laboratories, Inc reported sales of 2.60 billion Taiwanese Dollars (US$81.30 million)
December of 2015.
increase of 4.0%
versus 2014, when the company's sales were 2.50 billion Taiwanese Dollars.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Formosa Laboratories, Inc had sales
of 2.51 billion Taiwanese Dollars.